CSE suppressed the growth of human pancreatic cancer cells in vitro and in vivo through the induction of apoptosis via caspase-dependent pathways and possibly via ER stress-induced apoptosis and activation of the MAPK and P53 signaling pathways. Here, TP53 is linked to pancreatic neoplasm.